• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微管相关蛋白 DCAMKL1 通过抑制 Runx2 调节成骨细胞功能。

The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2.

机构信息

State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.

出版信息

J Exp Med. 2013 Aug 26;210(9):1793-806. doi: 10.1084/jem.20111790. Epub 2013 Aug 5.

DOI:10.1084/jem.20111790
PMID:23918955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3754873/
Abstract

Osteoblasts are responsible for the formation and mineralization of the skeleton. To identify novel regulators of osteoblast differentiation, we conducted an unbiased forward genetic screen using a lentiviral-based shRNA library. This functional genomics analysis led to the identification of the microtubule-associated protein DCAMKL1 (Doublecortin-like and CAM kinase-like 1) as a novel regulator of osteogenesis. Mice with a targeted disruption of Dcamkl1 displayed elevated bone mass secondary to increased bone formation by osteoblasts. Molecular experiments demonstrated that DCAMKL1 represses osteoblast activation by antagonizing Runx2, the master transcription factor in osteoblasts. Key elements of the cleidocranial dysplasia phenotype observed in Runx2(+/-) mice are reversed by the introduction of a Dcamkl1-null allele. Our results establish a genetic linkage between these two proteins in vivo and demonstrate that DCAMKL1 is a physiologically relevant regulator of anabolic bone formation.

摘要

成骨细胞负责骨骼的形成和矿化。为了鉴定成骨细胞分化的新调控因子,我们使用基于慢病毒的 shRNA 文库进行了无偏正向遗传筛选。这项功能基因组学分析导致鉴定出微管相关蛋白 DCAMKL1(双皮质和 CAM 激酶样 1)是成骨作用的新调控因子。靶向敲除 Dcamkl1 的小鼠表现出骨量增加,这是由于成骨细胞的骨形成增加所致。分子实验表明,DCAMKL1 通过拮抗成骨细胞中的主转录因子 Runx2 来抑制成骨细胞的激活。在 Runx2(+/-) 小鼠中观察到的颅锁骨发育不全表型的关键元素被引入 Dcamkl1 缺失等位基因所逆转。我们的结果在体内建立了这两种蛋白质之间的遗传联系,并证明 DCAMKL1 是合成代谢性骨形成的生理相关调控因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/e7a9b07ddaee/JEM_20111790_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/0406409c28ec/JEM_20111790_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/e19eb43eb393/JEM_20111790_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/764aa0e09407/JEM_20111790R_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/41326b60ec9c/JEM_20111790_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/c9d5d7749b9c/JEM_20111790_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/b8827b37afad/JEM_20111790_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/e7a9b07ddaee/JEM_20111790_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/0406409c28ec/JEM_20111790_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/e19eb43eb393/JEM_20111790_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/764aa0e09407/JEM_20111790R_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/41326b60ec9c/JEM_20111790_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/c9d5d7749b9c/JEM_20111790_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/b8827b37afad/JEM_20111790_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31fc/3754873/e7a9b07ddaee/JEM_20111790_Fig7.jpg

相似文献

1
The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2.微管相关蛋白 DCAMKL1 通过抑制 Runx2 调节成骨细胞功能。
J Exp Med. 2013 Aug 26;210(9):1793-806. doi: 10.1084/jem.20111790. Epub 2013 Aug 5.
2
DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization.DCAMKL1编码一种与双皮质素具有同源性的蛋白激酶,该蛋白激酶调节微管聚合。
J Neurosci. 2000 Dec 15;20(24):9152-61. doi: 10.1523/JNEUROSCI.20-24-09152.2000.
3
Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice.Nell-1 是 Runx2 的关键功能介质,它部分挽救了 Runx2(+/-) 小鼠的颅顶骨缺陷。
J Bone Miner Res. 2011 Apr;26(4):777-91. doi: 10.1002/jbmr.267.
4
Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.Zfp521 通过依赖于 HDAC3 的 Runx2 活性衰减来控制骨量。
J Cell Biol. 2010 Dec 27;191(7):1271-83. doi: 10.1083/jcb.201009107. Epub 2010 Dec 20.
5
mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression.mTOR/Raptor 信号通路通过调节 Runx2 表达对小鼠成骨细胞分化起关键作用。
Cell Death Differ. 2017 Nov;24(11):1886-1899. doi: 10.1038/cdd.2017.110. Epub 2017 Jul 7.
6
Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.Pax2 通过 Runx2 对小鼠间充质干细胞的增殖和成骨分化是必需的。
Exp Cell Res. 2018 Oct 15;371(2):342-352. doi: 10.1016/j.yexcr.2018.08.026. Epub 2018 Aug 23.
7
Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II.多囊蛋白-1通过刺激成骨细胞特异性转录因子RUNX2-II来调节骨骼生成。
J Biol Chem. 2008 May 2;283(18):12624-34. doi: 10.1074/jbc.M710407200. Epub 2008 Mar 5.
8
Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.ADAM17 外切酶释放蛋白酶的表达受骨肉瘤和骨相关转录因子 RUNX2 的直接调控。
J Cell Biochem. 2018 Nov;119(10):8204-8219. doi: 10.1002/jcb.26832. Epub 2018 Jun 19.
9
Microtubule assembly affects bone mass by regulating both osteoblast and osteoclast functions: stathmin deficiency produces an osteopenic phenotype in mice.微管组装通过调节成骨细胞和破骨细胞的功能来影响骨量:stathmin 缺乏会导致小鼠出现骨质疏松表型。
J Bone Miner Res. 2011 Sep;26(9):2052-67. doi: 10.1002/jbmr.419.
10
An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation.Discoidin domain receptor 2 (DDR2) 在成骨细胞分化和软骨细胞成熟中的重要作用是通过调节 Runx2 的激活来实现的。
J Bone Miner Res. 2011 Mar;26(3):604-17. doi: 10.1002/jbmr.225.

引用本文的文献

1
Eriodictyol Alleviated LPS/D-GalN-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Cell Apoptosis via PI3K/AKT Signaling Pathway.橙皮苷通过抑制 PI3K/AKT 信号通路减轻 LPS/D-GalN 诱导的急性肝损伤。
Nutrients. 2023 Oct 12;15(20):4349. doi: 10.3390/nu15204349.
2
Molecular Mechanism of Mutational Disruption of DCLK1 Autoinhibition Provides a Rationale for Inhibitor Screening.DCLK1 自身抑制突变的分子机制为抑制剂筛选提供了依据。
Int J Mol Sci. 2023 Sep 13;24(18):14020. doi: 10.3390/ijms241814020.
3
Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway.

本文引用的文献

1
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database.一种将肽的串联质谱数据与蛋白质数据库中氨基酸序列相关联的方法。
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89. doi: 10.1016/1044-0305(94)80016-2.
2
Single-molecule transcript counting of stem-cell markers in the mouse intestine.单细胞转录组计数鉴定小鼠肠道干细胞标志物。
Nat Cell Biol. 2011 Nov 27;14(1):106-14. doi: 10.1038/ncb2384.
3
CK1epsilon is required for breast cancers dependent on beta-catenin activity.CK1epsilon 对于依赖β-catenin 活性的乳腺癌是必需的。
巨噬细胞 DCLK1 通过激活 RIP2/TAK1 信号通路促进肥胖诱导的心肌病。
Cell Death Dis. 2023 Jul 13;14(7):419. doi: 10.1038/s41419-023-05960-4.
4
GATA4-activated lncRNA MALAT1 promotes osteogenic differentiation through inhibiting NEDD4-mediated RUNX1 degradation.GATA4激活的长链非编码RNA MALAT1通过抑制NEDD4介导的RUNX1降解促进成骨分化。
Cell Death Discov. 2023 May 8;9(1):150. doi: 10.1038/s41420-023-01422-0.
5
Central gene transcriptional regulatory networks shaping monocyte development in bone marrow.骨髓中塑造单核细胞发育的中枢基因转录调控网络。
Front Immunol. 2022 Oct 11;13:1011279. doi: 10.3389/fimmu.2022.1011279. eCollection 2022.
6
Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma.双皮质素样激酶 1 是鳞状细胞癌的治疗靶点。
Mol Carcinog. 2023 Feb;62(2):145-159. doi: 10.1002/mc.23472. Epub 2022 Oct 11.
7
TET enzymes regulate skeletal development through increasing chromatin accessibility of RUNX2 target genes.TET 酶通过增加 RUNX2 靶基因的染色质可及性来调节骨骼发育。
Nat Commun. 2022 Aug 11;13(1):4709. doi: 10.1038/s41467-022-32138-x.
8
Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.抑制细胞周期蛋白依赖性激酶5(Cdk5)可增加成骨细胞分化和骨量,并改善骨折愈合。
Bone Res. 2022 Apr 6;10(1):33. doi: 10.1038/s41413-022-00195-z.
9
Soft coral-derived Aspernolide A suppressed non-small cell lung cancer induced osteolytic bone invasion via the c-Fos/NFATC1 signaling pathway.源自软珊瑚的曲霉内酯A通过c-Fos/NFATC1信号通路抑制非小细胞肺癌诱导的溶骨性骨侵袭。
J Thorac Dis. 2021 Oct;13(10):5996-6011. doi: 10.21037/jtd-21-1631.
10
Napabucasin Induces Mouse Bone Loss by Impairing Bone Formation via STAT3.那帕布卡辛通过STAT3损害骨形成诱导小鼠骨质流失。
Front Cell Dev Biol. 2021 Mar 18;9:648866. doi: 10.3389/fcell.2021.648866. eCollection 2021.
PLoS One. 2010 Feb 1;5(2):e8979. doi: 10.1371/journal.pone.0008979.
4
DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium.DCAMKL-1表达可识别成年小鼠肠道上皮中的簇状细胞而非干细胞。
Gastroenterology. 2009 Dec;137(6):2179-80; author reply 2180-1. doi: 10.1053/j.gastro.2009.06.072. Epub 2009 Oct 29.
5
Post-translational Regulation of Runx2 in Bone and Cartilage.Runx2在骨骼和软骨中的翻译后调控
J Dent Res. 2009 Aug;88(8):693-703. doi: 10.1177/0022034509341629.
6
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.人类癌症中致癌性PIK3CA突变下游的非AKT依赖性信号传导。
Cancer Cell. 2009 Jul 7;16(1):21-32. doi: 10.1016/j.ccr.2009.04.012.
7
Molecular mechanisms in coupling of bone formation to resorption.骨形成与骨吸收偶联的分子机制。
Crit Rev Eukaryot Gene Expr. 2009;19(1):73-88. doi: 10.1615/critreveukargeneexpr.v19.i1.40.
8
Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2.抑制成骨细胞中的微管组装可通过转录因子Gli2刺激骨形态发生蛋白2的表达及骨形成。
Mol Cell Biol. 2009 Mar;29(5):1291-305. doi: 10.1128/MCB.01566-08. Epub 2008 Dec 22.
9
Endochondral ossification is required for haematopoietic stem-cell niche formation.造血干细胞龛的形成需要软骨内成骨。
Nature. 2009 Jan 22;457(7228):490-4. doi: 10.1038/nature07547. Epub 2008 Dec 10.
10
The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry.用于质谱法进行全局磷酸化分析的SCX/IMAC富集方法。
Nat Protoc. 2008;3(10):1630-8. doi: 10.1038/nprot.2008.150.